Suppr超能文献

ClinicalTrials.gov上关于数字健康技术在神经学试验中发展情况的证据。

Evidence from ClinicalTrials.gov on the growth of Digital Health Technologies in neurology trials.

作者信息

Masanneck Lars, Gieseler Pauline, Gordon William J, Meuth Sven G, Stern Ariel D

机构信息

Department of Neurology, Medical Faculty University Hospital Düsseldorf, Düsseldorf, Germany.

Hasso Plattner Institute, University of Potsdam, Potsdam, Germany.

出版信息

NPJ Digit Med. 2023 Feb 10;6(1):23. doi: 10.1038/s41746-023-00767-1.

Abstract

Digital Health Technologies (DHTs) such as connected sensors offer particular promise for improving data collection and patient empowerment in neurology research and care. This study analyzed the recent evolution of the use of DHTs in trials registered on ClinicalTrials.gov for four chronic neurological disorders: epilepsy, multiple sclerosis, Alzheimer's, and Parkinson's disease. We document growth in the collection of both more established digital measures (e.g., motor function) and more novel digital measures (e.g., speech) over recent years, highlighting contexts of use and key trends.

摘要

数字健康技术(DHTs),如连接传感器,在改善神经学研究与护理中的数据收集以及增强患者权能方面具有独特的前景。本研究分析了在ClinicalTrials.gov上注册的针对四种慢性神经疾病(癫痫、多发性硬化症、阿尔茨海默病和帕金森病)的试验中DHTs使用情况的近期演变。我们记录了近年来在收集更成熟的数字测量指标(如运动功能)和更新颖的数字测量指标(如语音)方面的增长情况,突出了使用背景和关键趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afa8/9918454/91f4cefb9434/41746_2023_767_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验